You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Tappan Street Partners | 2,298,684 | 0 | 2,298,684 | 0 | 2,298,684 | 5.1% |
Follow Prasad Phatak And Chris Koranda's Tappan Street Partners
Page 1 of 5 – SEC Filing
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of
1934*
| Peregrine Pharmaceuticals, Inc. |
| (Name of Issuer) Common Stock par value $0.0001 per share |
| (Title of Class of Securities) 713661502 |
| (CUSIP Number) July 11, 2017 |
| (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
| ☒ | Rule 13d-1(b) | |
| ☐ | Rule 13d-1(c) | |
| ☐ | Rule 13d-1(d) |
* The remainder of
this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover
page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
Follow Avid Bioservices Inc. (NASDAQ:CDMO)
Follow Avid Bioservices Inc. (NASDAQ:CDMO)
Page 2 of 5 – SEC Filing
| CUSIP No . | 713661502 | Page 2 of 7 |
| 1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS | |||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) ☐ (b) ☐ | ||
| 3 | SEC USE ONLY | |||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, United State of America | |||
| NUMBER OF BENEFICIALLY EACH PERSON | 5 | SOLE VOTING POWER 2,298,684* | ||
| 6 | SHARED VOTING POWER 0 | |||
| 7 | SOLE DISPOSITIVE POWER 2,298,684* | |||
| 8 | SHARED DISPOSITIVE POWER 0 | |||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING 2,298,684* | |||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES | ☐ | ||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.1%*+ | |||
| 12 | TYPE OF REPORTING PERSON IA | |||
*As of July 11, 2017, Tappan Street Partners LLC possesses the
power to vote and dispose or direct the disposition of 2,298,684 shares, and as such may be deemed to beneficially own 2,298,684
shares.
+ Based on a total of 45,069,188 Shares outstanding as of July
10, 2017, as set forth in the Issuer’s most recent Form 10-K, filed July 14, 2017.
Follow Avid Bioservices Inc. (NASDAQ:CDMO)
Follow Avid Bioservices Inc. (NASDAQ:CDMO)
Page 3 of 5 – SEC Filing
| CUSIP No. | 713661502 | Page 4 of 7 |
| Item 1(a). | Name of Issuer: | Peregrine Pharmaceuticals, Inc. | |
| Item 1(b). | Address of Issuer’s Principal Executive Offices: | 14282 Franklin Avenue, Tustin, | |
| Item 2(a). | Name of Person Filing: Tappan Street Partners, LLC | ||
| Item 2(b). | Address of Principal Business Office or, if None, Residence: | ||
| 33 Irving Place, Third Floor, New York, NY 10003 | |||
| Item 2(c). | Citizenship: | ||
| United States | |||
| Item 2(d). | Title of Class of Securities: | ||
| Common Stock, $0.0001 par value per share | |||
| Item 2(e). | CUSIP Number: 731661502 | ||
| Item 3. | If This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a: | ||
| (a) | ☐ | Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). | |
| (b) | ☐ | Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). | |
| (c) | ☐ | Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). | |
| (d) | ☐ | Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). | |
| (e) | ☒ | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); | |
Follow Avid Bioservices Inc. (NASDAQ:CDMO)
Follow Avid Bioservices Inc. (NASDAQ:CDMO)
Page 4 of 5 – SEC Filing
| CUSIP No . | 731661502 | Page 5 of 7 |
| (f) | ☐ | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); | |
| (g) | ☐ | A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G); | |
| (h) | ☐ | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | |
| (i) | ☐ | A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3); | |
| (j) | ☐ | Group, in accordance with §240.13d-1(b)(1)(ii)(J). | |
| Item 4. | Ownership. | ||
| Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. | |||
| (a) | Amount beneficially owned: 2,298,684* | ||
| (b) | Percent of class: 5.1%*+ | ||
| (c) | Number of shares as to which such person has: | ||
| (i) | Sole power to vote or to direct the vote 2,298,684* | ||
| (ii) | Shared power to vote or to direct the vote | ||
| 0 | |||
| (iii) | Sole power to dispose or to direct the disposition of 2,298,684* | ||
| (iv) | Shared power to dispose or to direct the disposition of | ||
| 0 | |||
Follow Avid Bioservices Inc. (NASDAQ:CDMO)
Follow Avid Bioservices Inc. (NASDAQ:CDMO)
Page 5 of 5 – SEC Filing
| CUSIP No . | 713661502 | Page 6 of 7 |
| Item 5. | Ownership of Five Percent or Less of a Class. |
| If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐ | |
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| Item 8. | Identification and Classification of Members of the Group. |
| Item 9. | Notice of Dissolution of Group. |
| Item 10. | Certification. |
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §
240.14a-11.
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true, complete and correct.
| Date: | July 20, 2017 | |
| Signature: | /s/ Prasad Phatak | |
| Name: | ||
| TAPPAN STREET PARTNERS, LLC | ||
| Date: | July 20, 2017 | |
| By: | /s/ Prasad Phatak | |
| Name: | ||
| Title: | Managing Member | |
